Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $21.00 (Singular Research)
- Lowest: $15.00 (TD Cowen)
- Average: $18.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.00 (+804.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 60%
Avg. $ Target:
$18.00 (+804.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 60%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Underweight (N/A) |
N/A (N/A) |
2.12 (1.99) |
-6.13% | Details |
| 8/29/2023 | Benchmark | Robert Wasserman | Downgrade | Hold (Buy) |
N/A (N/A) |
4.42 (1.99) |
-54.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
